Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Statement re Possible Offer

15 Sep 2008 07:39

RNS Number : 4040D
Creston PLC
15 September 2008
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THEΒ UNITED STATES OF AMERICA,Β CANADA,Β AUSTRALIAΒ ORΒ JAPAN

15Β September 2008

FOR IMMEDIATE RELEASE

CrestonΒ plc

Possible OfferΒ for Creston plc

The Board of Creston plc ("Creston" or the "Company") on 12 September 2008 announced that it is in discussions regarding a possible offer for the Company.

Creston today confirms that the possible offer has been received from a private equity firm ("Potential Offeror") which intends, subject to an offer being made and completed, to offer senior management positions and equity participations to Don Elgie, Creston's Chief Executive and Barrie Brien, Creston's Chief Financial Officer, and to other senior members of the Creston management team. The Board, therefore, has formed a committee of Independent Directors comprising Creston's non-executive Chairman, David Marshall and its two non-executive directors, Andrew Dougal and Malcolm Wall.

Although the Potential Offeror is in the final stages of its due diligence and the arranging of finance, the Independent Directors, who are being advised by Rothschild, wish to highlight that there can be no certainty that an offer will be made.

This statement is being made without the agreement or approval of the Potential Offeror and consequently there can be no certainty that an offer will be made nor as to the terms on which any offer might be made.Β 

A further announcement will be made when appropriate.

END

Rothschild is acting as financial adviser to Creston and no one else in connection with this announcement and will not be responsible to anyone other than Creston for providing the protections afforded to clients of Rothschild or for providing advice in relation to the contents of this announcement, or for any other transaction, arrangement or matters referred to in this announcement.

Investec is acting as corporate broker to Creston and no one else in connection with this announcement and will not be responsible to anyone other thanΒ CrestonΒ for providing the protections afforded to clients of Investec or for providing advice in relation to the contents of this announcement, or for any other transaction, arrangement or matters referred to in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
OFDGUURWBUPRUQA
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.